Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
28,406,191
Total 13F shares
23,633,959
Share change
+324,366
Total reported value
$677,565,550
Put/Call ratio
172%
Price per share
$28.68
Number of holders
142
Value change
+$11,461,219
Number of buys
71
Number of sells
62

Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) as of Q2 2023

As of 30 Jun 2023, Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) was held by 142 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,633,959 shares. The largest 10 holders included FEDERATED HERMES, INC., BlackRock Inc., STATE STREET CORP, ARK Investment Management LLC, VANGUARD GROUP INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Woodline Partners LP, FMR LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 143 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.